August 18, 2017

August 18, 2017

Laughter is the best medicine in cancer battle
WTVT - Aug. 18
A bucket list trip. That's how a Bay Area woman celebrated a new round of grueling chemotherapy to fight cancer. But why travel hen she was not feeling well and fighting a disease that could kill her? Patty Virgilio says Route 66 was the best kind of medicine.

Women of Red Ultimate Football Party
WTSP - Aug. 18
This will be supported by the Moffitt Cancer Center and is filled with a night of football and fun.

This Woman’s Facebook Post Is a Reminder That You Don't Have to Be a Smoker to Get Lung Cancer
Self Magazine – Aug. 17
Although it happens more often than you might think, lung cancer is still relatively uncommon among non-smokers, Tawee Tanvetyanon, M.D., M.P.H., a medical oncologist at Moffitt Cancer Center, tells SELF. But there are still a few signs to watch out for, just in case.

Biomarker-guided Radiotherapy Dosing Shows Promise for High-risk Liver Cancer Patients
MedScape – Aug. 17
Dr. Jessica Frakes of Moffitt Cancer Center, Tampa, Florida, told Reuters Health by email, “This study is an example of personalized radiation medicine entering the clinic for patients with varying degrees of liver dysfunction.”

Workouts lead to ultimate victory
Citrus County Chronicle – Aug. 16
Two years ago Tchir moved from Citrus County to Tampa, where she works as a lab assistant in the histology department at Moffitt Cancer Center. She routinely visits her parents and brother in Pine Ridge and they all exercise together.

How to Help Young Patients Preserve Their Fertility
ASCO Post – August 2017 Issue
The ASCO Post talked with Dr. Quinn, Senior Member in the Health Outcomes and Behavior Program at Moffitt Cancer Center and Professor in the Department of Oncologic Sciences at Morsani College of Medicine at the University of South Florida, about the results of her study; how to improve the rates of fertility preservation discussions; and when oncologists should initiate the conversation of cancer-related fertility risk with their AYA patients.

This kiosk offers a dough-licious new treat
The Laker/Lutz News – Aug. 16
Sanchez works at Moffitt Cancer Center, and helps out as her schedule permits.

Patients aid doctor with leukemia
Winter Haven Sun – Aug. 16
Miller’s spouse, C.R. Junkins, said chances are slim that one of people genetically tested at Bond Clinic Saturday will be a bone marrow match but staff at Moffitt Cancer Center believe a healthy match can be found in a global search.

Age of Patients With Thin Melanomas a Consideration in SLNB Recommendations
Cancer Network – Aug. 16
In an editorial published with the study, Vernon K. Sondak, MD, of Moffitt Cancer Center in Tampa, Florida, and colleagues wrote that clinicians must improve their ability to individualize decision-making for the use of SLNB in in patients with thin melanoma.

Local Hooters Has Donated $50K to Moffitt Cancer Center in Support of Breast Cancer Research
Press Release Point – Aug. 16
Hooters Management Corp. (HMC) presented a $50,000 donation to Moffitt Cancer Center, to educate providers, advocates and patients about immunotherapy in breast cancer to enhance clinical trial participation. 

Dr. Chavez Shares His Advice for Treating Patients With CLL
OncLive – Aug. 16
Julio Chavez, MD, of the Department of Malignant Hematology at Moffitt Cancer Center, shares his advice for oncologists treating patients with chronic lymphocytic leukemia (CLL).

Advances in Understanding of Penile Carcinogenesis: The Search for Actionable Targets
International Journal of Molecular Sciences – Aug. 16
Penile cancer (PeCa) is a rare malignancy with potentially devastating effects. Squamous cell carcinoma is the most common variant with distinct precancerous lesions before development into invasive disease. Involvement of the inguinal lymph nodes is the most important prognostic factor in PeCa, and once disease is present outside the groin, prognosis is poor.

Dr Lee Newcomer on UnitedHealthcare's Value-Based Contracts
AJMC – Aug. 15
We’ve done 2 types of contracts. The first is a bundle where it’s a single payment for every service the patient gets for a defined period of time, and we’ve done one at MD Anderson Cancer Center and another one at Moffitt Cancer Center. The problem with those is that you have to put in very narrow definitions in order to make the bundle fair for both the provider and for us and so it’s hard to get enough volume. So, right now I’d have to say that it has limited value.

UnitedHealthcare exec says gain-sharing value-based contracts work better than bundles
Becker’s Hospital Review – Aug. 15
Dr. Newcomer said one type of value-based contract involves bundled payments, which UnitedHealthcare deployed at Houston-based MD Anderson Cancer Center and Moffitt Cancer Center in Tampa, Fla. 

Lung Cancer: How to Protect Yourself From Blood Clots
True Viral News – Aug. 15
“People with lung cancer may have shortness of breath already, so you need to be aware of this danger,” says Jacques-Pierre Fontaine, MD, a thoracic surgeon at Moffitt Cancer Center in Tampa, Florida.

Dr. Chavez Discusses Ibrutinib Plus Venetoclax in CLL
OncLive – Aug. 14
Julio Chavez, MD, of the Department of Malignant Hematology at Moffitt Cancer Center, discusses ibrutinib (Imbruvica) plus venetoclax (Venclexta) in chronic lymphocytic leukemia (CLL).

Jazz Pharmaceuticals Announces FDA Approval of Vyxeos
Pharmacy Choice – Aug. 14
“Vyxeos is the first chemotherapy to demonstrate an overall survival advantage over the standard of care in a Phase 3 randomized study of older adults with newly-diagnosed therapy-related AML or AML with myelodysplasia-related changes," said Jeffrey E. Lancet, MD, Chair of the Department of Malignant Hematology at Moffitt Cancer Center. 

HPV e câncer masculino
Agencia FAPESP – Aug. 14
O HIM já gerou dezenas de artigos científicos. Três deles, publicados entre 2015 e 2017, trazem uma análise mais detalhada da história natural da infecção por HPV. Em dois papers, o grupo da epidemiologista Anna Giuliano, do Moffitt Cancer Center, na Flórida, coordenadora geral do HIM, relata os resultados da avaliação de cerca de 3 mil desses homens.

FDA approves liposome-encapsulated combination of daunorubicin-cytarabine for adults with AML
CPHI – Aug. 13
"Vyxeos is the first chemotherapy to demonstrate an overall survival advantage over the standard of care in a Phase III randomized study of older adults with newly-diagnosed therapy-related AML or AML with myelodysplasia-related changes," said Jeffrey E. Lancet, Chair of the Department of Malignant Hematology at Moffitt Cancer Center. 

Dr. Shah on Options for Ibrutinib-Intolerant Patients With MCL
OncLive – Aug. 11
Bijal D. Shah, MD, medical oncology, Moffitt Cancer Center, discusses a therapeutic option on the horizon for patients with mantle cell lymphoma (MCL) who are intolerant to ibrutinib (Imbruvica).

###

Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.